The DOI matches its Crossref record; 203 of the 212 references it cites were found in a registry or an index.
Calcific aortic valve disease: mechanisms, prevention and treatment
Abstract
Calcific aortic valve disease (CAVD) is the most common disorder affecting heart valves and is characterized by thickening, fibrosis and mineralization of the aortic valve leaflets. Analyses of surgically explanted aortic valve leaflets have shown that dystrophic mineralization and osteogenic transition of valve interstitial cells co-occur with neovascularization, microhaemorrhage and abnormal production of extracellular matrix. Age and congenital bicuspid aortic valve morphology are important and unalterable risk factors for CAVD, whereas additional risk is conferred by elevated blood pressure and plasma lipoprotein(a) levels and the presence of obesity and diabetes mellitus, which are modifiable factors. Genetic and molecular studies have identified that the NOTCH, WNT-β-catenin and myocardin signalling pathways are involved in the control and commitment of valvular cells to a fibrocalcific lineage. Complex interactions between valve endothelial and interstitial cells and immune cells promote the remodelling of aortic valve leaflets and the development of CAVD. Although no medical therapy is effective for reducing or preventing the progression of CAVD, studies have started to identify actionable targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
Clinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804602 · Cited by 1,644
Mutations in NOTCH1 cause aortic valve disease
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03940 · Cited by 1,509
Epelman, S., Lavine, K. J., Beaudin, A. E., Sojka, D. K., Carrero, J. A., Calderon, B., Brija, T., Gautier, E. L., Ivanov, S., Satpathy, A. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.019 · Cited by 1,494
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
Cowell, S. J., Newby, D. E., Prescott, R. J., Bloomfield, P., Reid, J., Northridge, D. B., & Boon, N. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043876 · Cited by 1,146
Landscape of X chromosome inactivation across human tissues
GTEx Consortium, Tukiainen, T., Villani, A.-C., Yen, A., Rivas, M. A., Marshall, J. L., Satija, R., Aguirre, M., Gauthier, L., Fleharty, M., et al. (2017) · Nature · doi:10.1038/nature24265 · Cited by 1,138
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Tsimikas, S., Karwatowska-Prokopczuk, E., Gouni-Berthold, I., Tardif, J.-C., Baum, S. J., Steinhagen-Thiessen, E., Shapiro, M. D., Stroes, E. S., Moriarty, P. M., Nordestgaard, B. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1905239 · Cited by 1,094
Research works printed but not linked: 1
- Monaghan, M. G. et al. Endocardial-to-mesenchymal transformation and mesenchymal cell colonization at the onset of human cardiac valve development. Development 143, 473–482 (2016).
Cited by
Lumican promotes calcific aortic valve disease through H3 histone lactylation
Huang, Y., Wang, C., Zhou, T., Xie, F., Liu, Z., Xu, H., Liu, M., Wang, S., Li, L., Chi, Q., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae407 · Cited by 124
Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021
Chen, Q., Shi, S., Wang, Y., Shi, J., Liu, C., Xu, T., Ni, C., Zhou, X. K., Lin, W., Peng, Y., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.037991 · Cited by 95
“8,25 As the world’s population ages, the impact of CAVD on the burden of illness and associated mortality is becoming more significant for several reasons.”
Osteopontin/SPP1: a potential mediator between immune cells and vascular calcification
Zhao, Y., Huang, Z., Gao, L., Ma, H., & Chang, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395596 · Cited by 104
Wang, C., Liu, Z., Zhou, T., Wu, J., Feng, F., Wang, S., Chi, Q., Sha, Y., Zha, S., Shu, S., et al. (2025) · iMeta · doi:10.1002/imt2.70048 · Cited by 83
“…valve disease (CAVD) is defined as a complex and chronic condition that comprises a continuum of pathological changes ranging from microscopic changes to a buildup of the extracellular matrix, aortic thickening, stenosis, and arrhythmia, culminating in heart failure and premature death [1, 2].”
Phospholipid-derived lysophospholipids in (patho)physiology
Prabutzki, P., Schiller, J., & Engel, K. M. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118569 · Cited by 79
Metadata
- Authors
- Moncla, L.-H. M., Briend, M., Bossé, Y., & Mathieu, P.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Université Laval (CA)
- Corresponding author
- Mathieu, Patrick
- Venue
- Nature Reviews Cardiology
- Published
- 2023-02-24
- Volume
- 20
- Issue
- 8
- Pages
- 546-559
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W4321790500
- Cited by
- 306
- References
- 212
- Citations by year
- 2026: 78 · 2025: 124 · 2024: 97 · 2023: 7
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- calcific aortic valve disease, aortic valve leaflet calcification, valvular interstitial cells, osteogenic differentiation, neovascularization, extracellular matrix, bicuspid aortic valve, risk factors, lipoprotein(a), Notch signaling, Wnt/β-catenin signaling, immune cells, disease prevention, treatment goals
- MeSH terms
- Aortic Valve, Aortic Valve Stenosis, Calcinosis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calcific aortic valve disease: mechanisms, prevention and treatment. https://app.cochat.ai/papers/10.1038/s41569-023-00845-7
- The paper
- Moncla, L.-H. M., Briend, M., Bossé, Y., & Mathieu, P. (2023). Calcific aortic valve disease: mechanisms, prevention and treatment. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-023-00845-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.